ClinicalTrials.gov
ClinicalTrials.gov Menu

Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00006262
Recruitment Status : Terminated (Unable to accrue patients to the study.)
First Posted : March 25, 2004
Last Update Posted : June 11, 2012
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Northwestern University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2001
  Actual Study Completion Date : September 2001
  Certification/Extension First Submitted : February 16, 2011